Kims Hospital

With robust cash flows and strategic expansions, Max is well-positioned for continued profitability and growth, while analysts expect KIMS to continue to be one of the fastest-growing hospital chains

The uptick in the company's stock price follows healthy financial results for the second quarter of FY24, reported on Saturday, November 9, 2024

KIMS, Monarch Networth can potentially rally up to 11% from adjusted stock price; whereas, Bigbloc Construction and Andhra Papers may witness weakness in the near-term; suggests technical charts.

KIMS share price zoomed after the hospital chain on Tuesday announced that it has set September 13, 2024, as the record date for its 5-for-1 stock split

Technical charts suggests that Ramkrishna Forgings, Balkrishna Industries and KIMS can potentially rally up to 16 per cent from present levels; check key support, resistance levels here

Solara Active Pharma Sciences, Indoco Remedies, Dishman Carbogen Amcis, Krishna Institute of Medical Sciences, Divi's Lab, Strides Pharma, Narayana Hrudayalaya and Vijaya Diagnostic were up 5 per cent

The uptick in stock price came after KIMS announced that it has entered into a definitive agreement for acquisition of a 200-bed multi-specialty hospital at a prime location in Vizag

Shares of Krishna Institute of Medical Sciences (KIMS) shot up to 6.4 per cent at Rs 2187 per share on the BSE in Tuesday's intraday deals

Stocks to watch on June 25: Swan Energy is set to acquire a 49 per cent equity stake in Triumph Offshore Private Ltd (TOPL) from Indian Farmers Fertiliser Cooperative Ltd (IFFCO) for Rs 440 crore

Across Asia, trading sentiment dipped as retail sales data fell short of street expectations, with a modest 2.3 per cent increase in April compared to the previous year

SBI Life Insurance Company on Tuesday bought shares of Krishna Institute of Medical Sciences (KIMS) for Rs 239 crore through an open market transaction. According to the bulk deal data available with the BSE, SBI Life Insurance Company Ltd purchased 11.49 lakh shares, representing a 1.4 per cent stake in KIMS. The shares were picked up at an average price of Rs 2,085 apiece, taking the deal size to Rs 239.58 crore. Meanwhile, ICICI Ventures' affiliate India Advantage Fund S4 I sold 10,70,545 shares at the same price. On Tuesday, shares of KIMS rose 1.93 per cent to settle at Rs 2,130.40 apiece on the BSE.

Blackstone's investment commitment combining QCIL and KIMS is close to $1 bn

Stocks to watch today: Bajaj Finance said that new loans booked during Q3FY23 were the highest-ever at 7.8 million

Apollo Hospitals Enterprise, and Narayana Hrudayalaya advanced 3 per cent each in the intra-day trade

On the broader market outlook, the technical analyst sees 18,350 as the next resistance for the Nifty 50, and support at 17,800-level.

These five stocks were are trading with strong gains on Wednesday despite the nervouss undertone in the broader market ahead of US Fed rate decision later tonight.

General Atlantic Singapore on Monday offloaded 12.10 lakh shares of hospital chain Krishna Institute of Medical Sciences (KIMS) for over Rs 151 cr through an open market transaction. According to bulk deal data available with BSE, General Atlantic Singapore Kh Pte sold 12,10,000 shares, amounting to 1.5 per cent stake in the company. The shares were disposed of at an average price of Rs 1,250 apiece, taking the transaction size to Rs 151.25 crore. ICICI Prudential Life Insurance Company Ltd picked up the shares at the same price. As on June quarter, General Atlantic owned 17.24 per cent stake in the company, shareholding pattern with the exchange showed. In early September, General Atlantic Singapore had disposed of 16.60 lakh shares of the company. KIMS shares closed 0.51 per cent lower at Rs 1,218.60 on BSE. In a separate transaction, promoter entity of Advanced Enzyme Technologies Ltd offloaded shares of the company for over Rs 69 crore through an open market transaction. Ad

Stock market LIVE: The Bank Nifty ended 2 per cent higher at fresh record highs, while the broader indices - both BSE Mdicap and Smallcap declined around 1.7 per cent each

The company said growth during Q1 FY22 was on account of contribution from ECMO and Heart & Lung Transplant program, which has doubled compared to previous quarter

With this investment, True North will acquire about 40 per cent stake in KIMS